Acute kidney injury: Lessons from experimental models

Contributions to Nephrology

Volumn 169, Issue , 2011, Pages 286-296

  Heyman, Samuel N ^a   Rosenberger, Christian ^b   Rosen, Seymour ^c  

^a HEBREW UNIVERSITY   (Israel)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL; APOPTOSIS; ARTICLE; DISEASE MODEL; HUMAN; KIDNEY TUBULE NECROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY TUBULAR NECROSIS, ACUTE;

EID: 79551489395     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000313957     Document Type: Article

References (87)

1. Heyman SN, Rosen S, Rosenberger C: Critical assessment of experimental models of acute renal failure; in Ronco C, Bellomo R, Kellum J (eds): Critical Care Nephrology, ed 2. Philadelphia, Saunders/Elsevier, 2009, pp 237-250.
2. Heyman SN, Rosen S, Rosenberger C. Animal models of renal dysfunction: acute kidney injury. Expert Opin Drug Discov 2009;4:629-641.
3. Heyman SN, Rosenberger C, Rosen S. Experimental ischemia-reperfusion - biases and myths: the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int 2010;77:9-16.
4. Rosen S, Heyman SN: Difficulties in understanding human acute tubular necrosis: limited data and flawed animal models. Kidney Int 2001;60:1220-1224.
5. Rosen S, Stillman IE: Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol 2008;19:871-875.
6. Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995;332:647-655.
7. Clanton TL: Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol 2007;102:2379-2388.
8. Rosenberger C, Heyman SN, Rosen S, et al: Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int 2005;67:531-542.
9. Rosenberger C, Goldfarb M, Shina A, Bachmann S, Frei U, Eckardt KU, Schrader T, Rosen S, Heyman SN: Evidence for sustained renal hypoxia and transient hypoxia adaptation in experimental rhabdomyolysisinduced acute kidney injury. Nephrol Dial Transpl 2008;23:1135-1143.
10. Yasuda H, Yuen PS, Hu X, Zhou H, Star RA: Simvastatin improves sepsisinduced mortality and acute kidney injury via renal vascular effects. Kidney Int 2006;69:1535-1542.
11. Kellum JA, Levin N, Bouman C, Lameire N: Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8:509-514.
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI Workgroup: Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative(ADQI) Group. Crit Care 2004;8:R204-R212.
13. Bagshaw SM, George C, Bellomo R: A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transpl 2008;23:1569-1574. (Pubitemid 351767782)
14. Li X, Hassoun HT, Santora R, Rabb H: Organ crosstalk: the role of the kidney. Curr Opin Crit Care 2009;15:481-487.
15. Jaffe R, Ariel I, Beeri R, Paltiel O, Hiss Y, Rosen S, Brezis M: Frequent apoptosis in human kidneys after acute renal hypoperfusion. Exp Nephrol 1997;5:399-403.
16. Beeri R, Symon Z, Brezis M, Ben- Sasson SA, Baehr PH, Rosen S, Zager RA: Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47:1806-1810.
17. Yokomaku Y, Sugimoto T, Kume S, et al: Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008;19:321-328.
18. Kindt N, Menzebach A, Van de Wouwer M, Betz I, De Vriese A, Conway EM: Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure. FASEB J 2008;22:510-521.
19. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Campean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008;19:486-494.
20. Langworthy M, Zhou B, de Caestecker M, Moeckel G, Baldwin HS: NFATc1 identifies a population of proximal tubule cell progenitors. J Am Soc Nephrol 2009;20:311-321.
21. Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, Hu X, Zhou H, Doi K, Childs R, Klinman DM, Yuen PS, Star RA: Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 2008;294:F1050-F1058.
22. Rahimtoola S: The hibernating myocardium. Am Heart J 1989;117:211-221.
23. Elsaesser A, Vogt AM, Nef H, Kostin S, Moellmann H, Skwara W, Bode C, Hamm, C, Schaper J: Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol 2004;43:2191-2199.
24. Kato H, Kogure K: Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol 1999;19:93-108.
25. Brezis M, Kopolovic J, Rosen S: Hypoxic injury to medullary thick ascending limbs in perfused rat kidneys: reversible and irreversible phases. J Electron Microsc Tech 1988;9:293-298.
26. Heyman SN, Brezis M, Reubinoff CA, et al: Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-412.
27. Agmon Y, Peleg H, Greenfeld Z, et al: Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994;94:1069-1075.
28. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991;40:632-642.
29. Racusen LC: Epithelial cell shedding in acute renal injury. Clin Exp Pharmacol Physiol 1998;25:273-275.
30. Bolisetty S, Traylor AM, Kim J, et al: Heme Oxygenase-1 Inhibits Renal Tubular Macroautophagy in Acute Kidney Injury. J AM Soc Nephrol 2010;21:1702-1712.
31. Terada N, Ohno N, Saitoh S, Ohno S: Immunohistochemical detection of hypoxia in mouse liver tissues treated with pimonidazole using in vivo cryotechnique. Histochem Cell Biol 2007;128:253-261.
32. Rosenberger C, Rosen S, Paliege A, Heyman SN: Pimonidazole adduct immunohistochemistry in the rat kidney: detection of tissue hypoxia. Methods Mol Biol 2009;466:161-174.
33. Rosenberger C, Rosen S, Heyman SN: Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006;33:980-988.
34. Webb JD, Coleman ML, Pugh CW: Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol Life Sci 2009;66:3539-3554.
35. Maxwell PH: HIF-1s relationship to oxygen: simple yet sophisticated. Cell Cycle 2004;3:156-159.
36. Metzen E, Ratcliffe PJ: HIF hydroxylation and cellular oxygen sensing. Biol Chem 2004;385:223-230.
37. Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Phy siology 2004;19:176-182.
38. Rosenberger C, Shina A, Rosen S, Goldfarb M, Eckardt K, Heyman SN: Hypoxia inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int 2006;70:60-70.
39. Hill P, Shukla D, Tran MG, et al: Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008;19:39-46.
40. Rosenberger C, Pratschke J, Rudolph B, et al: Immunohistochemical detection of hypoxia-inducible factor- 1alpha in human renal allograft biopsies. J Am Soc Nephrol 2007;18: 343-351.
41. Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J: Technology insight: biomarker development in acute kidney injury - what can we anticipate? Nat Clin Pract Nephrol 2008;4:154-165.
42. Nguyen MT, Devarajan P: Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008;23:2151-2157.
43. Prasad PV, Edelman RR, Epstein FH: Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996;94:3271-3275.
44. Ries M, Basseau F, Tyndal B, et al: Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 2003;17: 104-113.
45. Hofman L: BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int 2006;70:144-150.
46. 2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int 1999;55:294-298.
47. Prasad PV, Priatna A, Spokes K, Epstein FH: Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy. J Magn Reson Imaging 2001;13:744-747.
48. Maril N, Margalit R, Rosen S, et al: Detection of evolving acute tubular necrosis with renal 23Na MRI: studies in rats. Kidney Int 2006;69:765-768.
49. Atthe BK, Babsky AM, Hopewell PN, Phillips CL, Molitoris BA, Bansal N: Early monitoring of acute tubular necrosis in the rat kidney by 23Na-MRI. Am J Physiol Renal Physiol 2009;297:F1288-F1298.
50. Maril N, Rosen Y, Reynolds GH, Ivanishev A, Ngo L, Lenkinski RE: Sodium MRI of the human kidney at 3 Tesla. Magn Reson Med 2006;56:1229-1234.
51. Rosen Y, Lenkinski RE: Sodium MRI of a human transplanted kidney. Acad Radiol 2009;16:886-889.
52. Miyabe H, Ohte N, Iida A, Narita H, Yoshida T, Kimura G: Evaluation of fatty acid beta-oxidation in patients with prior myocardial infarction in relation to myocardial blood flow, total oxidative metabolism, and left ventricular wall motion. Circ J 2005;69:1459-1465.
53. Sorrentino AR, Acampa W, Petretta M, Mainolfi C, Salvatore M, Cuocolo A: Comparison of the prognostic value of SPECT after nitrate administration and metabolic imaging by PET in patients with ischaemic left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2007;34:558-562.
54. Heyman SN, Rosen S, Rosenberger C: Renal parenchymal hypoxia, hypoxia adaptation and the pathogenesis of radiocontrast nephropathy. Clinical J Am Soc Nephrol 2008;3:288-296.
55. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO: Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 2003;46:1153-1160.
56. De Vriese AS, Stoenoiu MS, Elger M, Devuyst O, Vanholder R, Kriz W, Lameire NH: Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide. Kidney Int 2001;60:202-210.
57. Zager RA: Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion. Am J Physiol 1988;254:F574-F581.
58. Zager RA: Escherichia coli endotoxin injections potentiate experimental ischemic renal injury. Am J Physiol 1996;251:F988-F994.
59. Heyman SN, Rosen S, Darmon D, Goldfarb M, Bitz H, Shina A, Brezis M: Endotoxin-induced renal failure: II. A role for tubular hypoxic damage. Exp Nephrol 2000;8:275-282.
60. Zager RA: Subclinical gentamicin nephrotoxicity: a potential risk factor for exaggerated endotoxin-driven TNF-alpha production. Am J Physiol Renal Physiol 2007;293:F325-F342.
61. Ramesh G, Zhang B, Uematsu S, et al: Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice. Am J Physiol Renal Physiol 2007;293:F325-F332. (Pubitemid 47345033)
62. Goldfarb M, Abassi Z, Rosen S, Shina A, Brezis M, Heyman SN: Chronic heart failure predisposes to hypoxic outer medullary tubular injury: studies in rats. Kidney Int 2001;60:607-613.
63. Heyman SN, Rosen S, Fuchs S, Epstein FH, Brezis M: Myoglobinuric acute renal failure in the rat: a role for medullary hypoperfusion, hypoxia and tubular obstruction. J Am Soc Nephrol 1996;7:1066-1074.
64. Zager RA, Johnson AC, Hanson SY, Lund S: Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/ chemokine production. Kidney Int 2006;69:1181-1188.
65. Heyman SN, Brezis M, Rosen S: The isolated perfused rat kidney model in experimental renal injury; in Bennett WM, DeBroe ME, Porter GA, Verpooten GA (eds): Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals. Dordrecht, Kluwer Academic Publishers, 1998, pp 77-82.
66. Bonventre JV: Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002;11:43-48.
67. Zager RA, Baltes LA, Sharma HM, Jurkowitz MS: Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 1984;26:689-700.
68. 2 deprivation injury, possibly by inducing uremia. Kidney Int 1994;45:1760-1768.
69. Shanley PF, Rosen MD, Brezis M, et al: Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol 1986;122:462-468.
70. Kwon TH, Frokiaer J, Han JS, et al: Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 2000;278:F925-F939.
71. Goldfarb M, Rosenberger C, Abassi Z, et al: Acute-on-chronic renal failure in the rat: functional compensation and hypoxia tolerance. Am J Nephrol 2006;26:22-33.
72. Orvieto MA, Zorn KC, Mendiola FP, et al: Ischemia preconditioning does not confer resilience to warm ischemia in a solitary porcine kidney model. Urology 2007;69:984-987.
73. Behrends M, Walz MK, Kribben A, et al: No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 2000;85:819-827.
74. Kosieradzki M, Ametani M, Southard JH, Mangino MJ: Is ischemic preconditioning of the kidney clinically relevant? Surgery 2003;133:81-90.
75. Reutzel-Selke A, Pratschke J, Martins PN, Denecke C, Jurisch A, Kotsch K, Pascher A, Neuhaus P, Tullius SG: Ischemic preconditioning produces systemic protective and adoptively transferable effects. Kidney Int 2008;74:622-630.
76. Zager RA, Johnson A: Renal cortical cholesterol accumulation is an integral component of the systemic stress response. Kidney Int 2001;60:2299-2310.
77. Zager RA, Johnson AC, Lund S: Endotoxin tolerance: TNF-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int 2007;71:496-503.
78. Nath KA: Renal response to repeated exposure to endotoxin: implications for acute kidney injury. Kidney Int 2007;71:477-479.
79. Ratcliffe PJ: Understanding hypoxia signalling in cells - a new therapeutic opportunity? Clin Med 2006;6:573-578.
80. Bernhardt WM, Câmpean V, Kany S, et al: Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006;17:1970-1978.
81. Rosenberger C, Rosen S, Shina A, Frei U, Eckardt KU, Flippin LA, Arend M, Klaus SJ, Heyman SN: Activation of hypoxia inducible factors (HIF) ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant 2008;23: 3472-3478.
82. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Campean V,Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008;19:486-494.
83. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schödel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU: Donor treatment with a PHDinhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 2009;106:21276-21281.
84. Goldfarb M, Rosenberger C, Shina A, et al: A role for erythropoietin in the attenuation of radiocontrast-induced acute renal failure in rats. Ren Fail 2006;28:345-350.
85. Yokomaku Y, Sugimoto T, Kume S, et al: Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008;19:321-328.
86. Johnson DW, Pat B, Vesey DA, et al: Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006;69:1806-1813.
87. Nath KA: Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 2006;70:432-443.